OUR MARKETING
SERVICES INCLUDE:

BioNews offers the next generation, “inbound” marketing approach to promoting and raising awareness for your company’s clinical trial, driving rare disease patient referrals through our incredibly niche rare disease digital platform.

Power your company’s clinical trial recruitment efforts through our network of disease-specific websites and social media, bringing together daily, optimized news content and vigorous social media activity and search engine exposure. This truly multi-channel, multi-content approach leverages niche marketing practices to ensure that only people who have an interest in the rare disease your company is focused on are exposed to your trail and messaging.

Our Clinical Trial Recruitment Process at a Glance:

  • Access to hard-to-reach rare disease patient populations & user groups.
  • Inbound marketing approach for high conversion rates.
  • Social media promotion of content for viral yet targeted promotion.
  • Search engine-driven clinical trial recruitment leads.
  • Valuable patient and user data for launching optimized campaigns.
Markting3
The unique user data on many of our rare disease sites indicate that we reach 100% of rare disease patient populations.
Markting11
Our user communities are highly engaged, with a majority visiting the site 3-5 times per week.
Markting10
Research into our user base reveals that 90%+ of our readers identify as patients or caregivers.
Markting2
96% of readers indicate that they trust the accuracy, independence, and authority our rare disease content.
Markting1
Our rare disease platforms are multi-channel, multi-content ecospheres that engage rare disease communities via e-mail, web content, and social media.

CONTACT US

For more information on our marketing services, contact info@bionewsservices.com, or fill out the form below.